Careers  |   Log In  |   Register  |   Welcome Center  |   Follow Us  Facebook  Twitter Google Plus
 
Course List


  • CME Information

Provider Statement

This continuing medical education activity is provided by Vindico Medical Education.

Support Statement

This activity is supported by an educational grant from Gilead Sciences Medical Affairs.

Target Audience

The intended audience for the activity is primary care physicians, family physicians/general practitioners, internal medicine physicians, infectious disease specialists, gastroenterologists/hepatologists and other health care professionals involved in the treatment and management of HCV.

Learning Objectives

Upon successful completion of the activity, participants should be better able to:

  • Evaluate the impact of early detection and intervention for patients with HCV on preventing disease progression, improving extrahepatic manifestations, and achieving cure.
  • Apply established screening guidelines to the early and accurate detection of HCV.
  • Identify patients with HCV infection who may be easily treated in the primary care setting or refer to a specialist as warranted.
  • Implement effective follow-up, counseling, and quality care for patients upon confirmed diagnosis of HCV.
  • Differentiate new agents for HCV management based on safety, efficacy, and recommended usage.
  • Apply evidence-based treatment guidelines to the effective management of patients with HCV.

Faculty:

David R. Nelson, MD
Professor of Medicine
Assistant Vice President for Research
University of Florida
Gainesville, FL

Joseph K. Lim, MD
Associate Professor of Medicine
Director, Yale Viral Hepatitis Program
Yale University School of Medicine
New Haven, CT

Robert S. Brown, Jr., MD, MPH
Gladys and Roland Harriman Professor of Medicine
Vice Chair, Transitions of Care
Interim Chief
Division of Gastroenterology and Hepatology
Weill Cornell Medicine
New York, NY

Accreditation

Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Vindico Medical Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s) TM, 0.25 credits per video. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This enduring material is approved for 1 year from the date of original release, May 31, 2016 to May 30, 2017.

How To Participate in this Activity and Obtain CME Credit

To participate in this CME activity, you must read the objectives, answer the pretest questions, read the articles, complete the CME posttest, and complete the evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 66% of the posttest questions correctly for each video. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)TM Certificate.

External Reviewer

Craig Aronchick, MD

Disclosures:

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.

The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.

Planning Committee and Faculty members report the following relationship(s):

Robert S. Brown, Jr., MD, MPH
Consulting Fee: AbbVie, Bristol-Myers Squibb, Gilead, Janssen, Merck

Joseph K. Lim, MD
Consulting Fee: Bristol-Myers Squibb, Gilead, Janssen
Contracted Research: Bristol-Myers Squibb, Gilead, Janssen

David R. Nelson, MD
Contracted Research: AbbVie, Gilead, Janssen, Merck

External Reviewer reports the following relationship(s):
Craig Aronchick, MD
No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relationship(s):
No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Unlabeled and Investigational Usage:

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.

Copyright Statement:

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2016 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

CME Questions?

Contact us at CME@VindicoCME.com